Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.Blood|December 17, 2025
A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 StudyAndy Itsara, Victoria M Rogness, Laura Samples, et al.Leukemia & Lymphoma|September 30, 2014
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation methodElisabet E Manasanch, Dalia A Salem, Constance M Yuan, et al.Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.Blood|December 24, 2024
Non-V600E BRAF mutations and treatment for hairy cell leukemiaEvgeny Arons, Chin-Hsien Tai, Joshi Suraj, et al.Blood Advances|February 18, 2026
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?Flavia Gava, Bonnie Yates, Zhouxin Sun, et al.Pageof 7